Alcohol use disorder

Last updated: February 23, 2023

Alcohol use disorder

Gastroenterology

Gastroenterology

Diverticular disease: Pathology review
Malabsorption syndromes: Pathology review
Colorectal polyps and cancer: Pathology review
Peptic ulcers and stomach cancer: Clinical
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Gastric cancer
Anatomy of the abdominal viscera: Small intestine
Anatomy of the abdominal viscera: Large intestine
Intestinal atresia
Intestinal fluid balance
Intestinal adhesions
Intestinal malrotation
Inflammatory bowel disease: Clinical
Bowel obstruction
Small bowel ischemia and infarction
Irritable bowel syndrome
Inflammatory bowel disease: Pathology review
Small bowel bacterial overgrowth syndrome
Congenital gastrointestinal disorders: Pathology review
Peutz-Jeghers syndrome
Alcohol-associated liver disease
Liver anatomy and physiology
Liver histology
Benign liver tumors
Cholestatic liver disease
Non-alcoholic fatty liver disease
Hepatic encephalopathy
Wilson disease
Cirrhosis
Gastrointestinal system anatomy and physiology
Cystic fibrosis: Pathology review
Enteric nervous system
Bowel obstruction: Clinical
Ruptured spleen
Colorectal cancer
Colorectal cancer: Clinical
Antimetabolites for cancer treatment
Oral cancer
Abdominal pain: Clinical
Achalasia
Esophageal disorders: Clinical
Esophageal disorders: Pathology review
Esophageal surgical conditions: Clinical
Esophageal cancer
Gastroesophageal reflux disease (GERD): Clinical
Dyslipidemias: Pathology review
Ascending cholangitis
Primary sclerosing cholangitis
Cirrhosis: Pathology review
Jaundice: Clinical
Primary biliary cholangitis
Jaundice: Pathology review
Gallbladder disorders: Clinical
Cirrhosis: Clinical
Pancreatitis: Clinical
Pediatric gastrointestinal bleeding: Clinical
Superior mesenteric artery syndrome
Ischemia
Ischemic colitis
Gastrointestinal bleeding: Pathology review
Gastrointestinal bleeding: Clinical
Alcohol use disorder
Fetal alcohol syndrome
Pancreatitis: Pathology review
Wernicke-Korsakoff syndrome
Gluconeogenesis
Anorexia nervosa
Eating disorders: Clinical
Eating disorders: Pathology review
Bulimia nervosa
Pancreatic cancer
Pediatric vomiting: Clinical
Zinc deficiency and protein-energy malnutrition: Pathology review
Hepatitis A and Hepatitis E virus
Appendicitis: Clinical
Appendicitis
Appendicitis: Pathology review
Short bowel syndrome (NORD)
Intussusception
Gallstone ileus
Hernias: Clinical
Volvulus
Diverticular disease: Clinical
Non-Hodgkin lymphoma
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Diarrhea: Clinical
Celiac disease
Celiac disease: Nursing process (ADPIE)
Tropical sprue
Biliary colic
Malabsorption: Clinical
Food allergy
Vibrio cholerae (Cholera)
Antidiarrheals
Salmonellosis
Clostridium botulinum (Botulism)
Clostridium perfringens
Clostridium difficile (Pseudomembranous colitis)
Diffuse esophageal spasm
Inflammatory bowel disease: Pathology review
Small intestine histology
Peptic ulcer
Gastric motility
Zollinger-Ellison syndrome
Gallbladder histology
Helicobacter pylori
Pancreatic secretion
Chronic pancreatitis
Pyloric stenosis
Esophageal web
Esophageal motility
Boerhaave syndrome
Esophagitis: Clinical
Laxatives and cathartics
Anal conditions: Clinical
Abdominal hernias
Inguinal hernia
Femoral hernia
Congenital diaphragmatic hernia
Omphalocele
Gastroparesis: Clinical
Gastroparesis
Gallbladder carcinoma
Viral hepatitis
Hepatitis medications
Hepatitis B and Hepatitis D virus
Viral hepatitis: Clinical
Neonatal hepatitis
Hepatitis C virus
Viral hepatitis: Pathology review
Autoimmune hepatitis
Hepatitis D virus
Viral hepatitis: Pathology review
Prions (Spongiform encephalopathy)
Portal hypertension
Hepatocellular carcinoma
Hepatocellular adenoma
Neonatal jaundice: Clinical
Hirschsprung disease
Mallory-Weiss syndrome
Meckel diverticulum
Childhood nutrition and obesity: Information for patients and families (The Primary School)
Rectal prolapse
Pediatric constipation: Clinical
Ulcerative colitis
Familial adenomatous polyposis
Colorectal polyps
Vitamin B12 deficiency
Peritonitis
Abdominal trauma: Clinical
Enterobacter
Cystic fibrosis: Clinical
Acute cholecystitis
Microscopic colitis

Transcript

Watch video only

Alcohol is one of the most widely used psychoactive substances in the world, and has been a part of different cultures for hundreds of years.

Drinking alcohol can have serious harmful consequences, it’s been linked to various cancers, gastrointestinal diseases, and metabolic problems.

Over time, regular use of alcohol can lead to alcohol dependence and bouts of withdrawal, and this can take a serious physical and emotional toll on a person’s life.

Alcoholic drinks contain the chemical ethanol, which is a tiny molecule that reduces the activity of various inhibitory and excitatory neurotransmitter pathways in the brain.

Inhibitory neurotransmitters make neurons in the central nervous system less likely to fire an action potential, and the brain’s major inhibitory neurotransmitter—gamma-aminobutyric acid or GABA—acts as an “off” switch and restricts brain activity.

Ethanol is a GABA agonist, so when it binds to GABA receptors it makes that inhibitory signal even stronger.

Ethanol also activates opioid receptors and induces the release of endogenous morphine—known as endorphins.

The opioids then bind to receptors on dopaminergic neurons in the nucleus accumbens, which trigger the release of dopamine and serotonin in that part of the brain.

Ethanol also acts as a glutamate antagonist.

In other words, ethanol blocks glutamate, which is an excitatory neurotransmitter, from binding to glutamate receptors, making it less likely that those neurons will fire.

The combined effect that ethanol has on these neurotransmitters varies by the location in the brain.

For example, in the nucleus accumbens and the amygdala, which are the reward centers of the brain, ethanol produces pleasant or rewarding feelings like euphoria.

This is important because if a person believes that drinking leads to euphoria, they are more likely to drink again.

In the cerebral cortex, the thought-processing center of the brain, ethanol slows everything down, making it difficult to think and speak clearly.

Ethanol also slows behavioral inhibition centers like the prefrontal cortex, making people feel more relaxed and less self-conscious.

In the cerebellum, the area responsible for movement and balance, ethanol causes individuals to lose their coordination, making it harder to walk or do complex tasks like driving.

Ethanol also affects the hypothalamus and pituitary glands, which regulate various hormones and mood.

In these areas, ethanol typically increases sexual arousal, but decreases a person’s ability to engage in sex.

In the medulla, which controls automatic functions like breathing, consciousness, and body temperature, ethanol increases sleepiness, slows breathing, and lowers the body temperature to a point where it’s life-threatening.

Alcoholic drinks have varying amounts of ethanol.

For example, 355 ml or 12 fluid ounces of beer typically contains 5% ethanol by volume, 148 ml or 5 fluid ounces of wine has 12% ethanol by volume, and 44 ml or 1.5 fluid ounces of 80-proof distilled spirits like gin, rum, tequila, or whiskey contains 40% ethanol by volume, all three of these alcoholic drinks therefore have about 18 ml of pure ethanol.

Ethanol’s effects on a person are directly related to the blood alcohol content, or BAC, which is the percentage of ethanol in a given volume of blood.

BAC is affected by the amount of ethanol consumed as well as a person’s blood volume, which depends on their size and sex, as well as situational factors like how much they’ve had to eat or drink, what other substances or medications they may be using, and how well the body is prepared for the alcohol.

At a blood alcohol content of 0.0 to 0.05%, people typically feel relaxed and happy, but might have slurred speech, and some difficulty with coordination and balance.

At a blood alcohol content of 0.06 to 0.15%, there is more impairment in speech, memory, attention, and coordination, and some individuals can get aggressive and even violent.

Complex tasks like driving can become dangerous, which is why it is illegal to drive in some countries with a blood alcohol content of 0.08% or higher.

At a blood alcohol content of 0.16 to 0.30% individuals can experience alcohol poisoning with blackouts or periods of amnesia, vomiting, or even a loss of consciousness.

Finally, at a blood alcohol content above 0.31%, the effect of alcohol can severely suppress breathing and even lead to death.

Over time, individuals who consistently use alcohol can develop tolerance to its effects.

This means that with repeated use, they have a reduced response to alcohol, and therefore an increased dose is needed to achieve the original response.

At a cellular level, there are a couple theories that explain why this might happen.

One is that repeated exposure to ethanol may cause GABA, glutamate, dopamine, and serotonin receptors to become less sensitive to alcohol.

Another is that neurons may remove these receptors from the cell wall in a process called down-regulation, leaving fewer receptors available for binding.

In either scenario, tolerance leads to the need for higher and higher doses of alcohol, and often times that tolerance stays for a long time even after decreasing alcohol use.

Now, let’s say that you’re at rest, without alcohol or anything stimulating your reward pathway.

In this situation, your brain keeps your heart rate, blood pressure, and wakefulness in a normal state, called homeostasis.

Now, let’s say that your secret crush sends you a text.

All of a sudden you may feel sweaty and flushed, your heart rate may jump a bit.

You’re now above your normal level of homeostasis, because something has changed, right?

But it doesn’t stay that way for long, and after the text, your brain brings things back down to this baseline.

With repeated alcohol use, a few things start to happen.

Let’s say you drink at a specific time and setting, like 5pm in the kitchen, and, being a depressant, it makes everything go slower, including heart rate, blood pressure, and wakefulness.

Your brain, being the smart brain that it is, will pick up on that pattern for next time.

Now, next time, at 5pm in the kitchen, the brain preemptively increases functioning, since it knows that when you drink the alcohol, everything’s going to decrease.

Now, let’s say 5pm in the kitchen rolls around, but there’s no alcohol.

In that situation, the brain still increases heart rate and blood pressure, but the changes aren’t countered with the effects of alcohol, and so the person can feel awful, and these are called withdrawal symptoms.